1. A.07 Efficacy, safety, and tolerability of ubrogepant for the acute treatment of migraine: a single-attack phase 3 study, ACHIEVE I. (5th June 2019) Authors: Dodick, DW; Lipton, RB; Ailani, J; Lu, K; Lakkis, H; Finnegan, M; Trugman, JM; Szegedi, A; Davidovic, G Journal: Canadian journal of neurological sciences Issue: Volume 46(2019)Supplement 1 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A.07 Efficacy, safety, and tolerability of ubrogepant for the acute treatment of migraine: a single-attack phase 3 study, ACHIEVE I. (June 2019) Authors: Dodick, DW; Lipton, RB; Ailani, J; Lu, K; Lakkis, H; Finnegan, M; Trugman, JM; Szegedi, A; Davidovic, G Journal: Canadian journal of neurological sciences Issue: Volume 46(2019)Supplement 1 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine. Issue 7490 (11th February 2005) Authors: Szegedi, A; Kohnen, R; Dienel, A; Kieser, M Journal: BMJ Issue: Volume 330:Issue 7490(2005) Page Start: 503 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis. Issue 10 (13th April 2005) Authors: Aleksza, M; Szegedi, A; Antal-Szalmás, P; Irinyi, B; Gergely, L; Ponyi, A; Hunyadi, J; Sipka, S; Zeher, M; Szegedi, G; Dankó, K Journal: Annals of the rheumatic diseases Issue: Volume 64:Issue 10(2005) Page Start: 1485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P.010 Efficacy, safety, and tolerability of ubrogepant for the acute treatment of migraine: a single-attack phase 3 study, ACHIEVE II. (5th June 2019) Authors: Lipton, RB; Dodick, DW; Ailani, J; Lu, K; Lakkis, H; Finnegan, M; Szegedi, A; Trugman, JM; Davidovic, G Journal: Canadian journal of neurological sciences Issue: Volume 46(2019)Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P.010 Efficacy, safety, and tolerability of ubrogepant for the acute treatment of migraine: a single-attack phase 3 study, ACHIEVE II. (June 2019) Authors: Lipton, RB; Dodick, DW; Ailani, J; Lu, K; Lakkis, H; Finnegan, M; Szegedi, A; Trugman, JM; Davidovic, G Journal: Canadian journal of neurological sciences Issue: Volume 46(2019)Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗